News
A 30pc tariff on EU exports to the US could have a significant impact on Ireland’s economy, which could include potential job ...
A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences ...
Donald Trump has 'sparked alarm' by threatening a 50% tariff on non-US copper and a 200% tariff on imported pharmaceuticals.
Now a professor emerita still very engaged in trade issues, she joked that at least now her students no longer treated her ...
Whether it’s tariffs that impact its exports or a retaliatory EU digital services tax, Ireland stands to lose more acutely ...
Market research can identify ways to lower costs and improve revenues, if it is approached methodically. Here are some tips for success.
A Swiss-led initiative could potentially be game changer in helping healthworkers in remote areas have access to medical ...
This was mainly because of a £0.3 billion rise in chemical imports (Figure 4), driven by increased imports of medicinal and pharmaceutical products ... collection changes following Brexit, which ...
Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...
Britain said it would strike an agreement with Vietnam to make it easier for pharmaceutical firms to sell UK-made medicines ...
Irish-made medicines heading to the US face steep new duties, raising alarm among patients, producers and investors on both ...
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results